Caption Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$396M Buy
667,200
+444,400
+199% +$221M 2.31% 2
2025
Q4
$109M Sell
222,800
-30,800
-12% -$14.3M 0.74% 23
2025
Q3
$106M Buy
253,600
+203,500
+406% +$68.4M 0.83% 17
2025
Q2
$14.4M Buy
50,100
+5,100
+11% +$1.52M 0.16% 131
2025
Q1
$13.9M Buy
45,000
+25,000
+125% +$8.57M 0.13% 140
2024
Q4
$7.06M Buy
+20,000
New +$7.35M 0.07% 272
2024
Q3
Sell
-34,000
Closed -$10.8M 1598
2024
Q2
$10.8M Buy
+34,000
New +$9M 0.17% 131
2023
Q4
Sell
-15,000
Closed -$3.39M 1699
2023
Q3
$3.39M Hold
15,000
0.05% 438
2023
Q2
$3.31M Buy
+15,000
New +$3.32M 0.06% 380
2022
Q4
Sell
-60,000
Closed -$12.6M 1743
2022
Q3
$12.6M Buy
60,000
+40,000
+200% +$8.94M 0.17% 121
2022
Q2
$4.71M Buy
+20,000
New +$4.07M 0.07% 365
2022
Q1
Sell
-20,000
Closed -$4.32M 1973
2021
Q4
$4.32M Buy
+20,000
New +$3.93M 0.05% 500
2021
Q2
Sell
-15,000
Closed -$2.51M 1586
2021
Q1
$2.51M Buy
+15,000
New +$2.5M 0.05% 450
2019
Q4
Sell
-25,000
Closed -$1.99M 1013
2019
Q3
$1.99M Buy
+25,000
New +$2.01M 0.1% 238

Other funds holding UTHR

Caption Management's UTHR Position: Q1 2026 in Review

Caption Management increased its United Therapeutics (UTHR) stake by 35% in Q1 2026, buying an estimated $9.64M and bringing the position to 74,445 shares worth $44.1M. The position accounts for 0.26% of the portfolio, ranked #75.

Caption Management first reported a position in UTHR in Q3 2021 and has held it in 7 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Caption Management held 74,445 shares of United Therapeutics worth $44.1M as of Q1 2026.
  • Caption Management bought 19,364 United Therapeutics shares in Q1 2026, an estimated $9.64M.
  • United Therapeutics made up 0.26% of Caption Management's portfolio in Q1 2026, its #75 holding.
  • Caption Management first reported a position in United Therapeutics in Q3 2021 and has held it in 7 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.